- Home
- RGP vs BIOA Comparison
RGP vs BIOA Comparison
Compare RGP & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGP
- BIOA
- Stock Information
- Founded
- RGP 1996
- BIOA 2015
- Country
- RGP United States
- BIOA United States
- Employees
- RGP N/A
- BIOA N/A
- Industry
- RGP Business Services
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- RGP Consumer Discretionary
- BIOA Health Care
- Exchange
- RGP Nasdaq
- BIOA Nasdaq
- Market Cap
- RGP 155.0M
- BIOA 175.7M
- IPO Year
- RGP 2006
- BIOA 2024
- Fundamental
- Price
- RGP $4.42
- BIOA $8.00
- Analyst Decision
- RGP Buy
- BIOA Hold
- Analyst Count
- RGP 2
- BIOA 4
- Target Price
- RGP $6.00
- BIOA $7.33
- AVG Volume (30 Days)
- RGP 533.7K
- BIOA 548.4K
- Earning Date
- RGP 10-08-2025
- BIOA 11-06-2025
- Dividend Yield
- RGP 6.32%
- BIOA N/A
- EPS Growth
- RGP N/A
- BIOA N/A
- EPS
- RGP N/A
- BIOA N/A
- Revenue
- RGP $534,625,000.00
- BIOA $3,863,000.00
- Revenue This Year
- RGP N/A
- BIOA N/A
- Revenue Next Year
- RGP $12.36
- BIOA N/A
- P/E Ratio
- RGP N/A
- BIOA N/A
- Revenue Growth
- RGP N/A
- BIOA N/A
- 52 Week Low
- RGP $4.23
- BIOA $2.88
- 52 Week High
- RGP $9.96
- BIOA $25.33
- Technical
- Relative Strength Index (RSI)
- RGP 41.20
- BIOA 80.25
- Support Level
- RGP $4.27
- BIOA $5.05
- Resistance Level
- RGP $4.49
- BIOA $5.52
- Average True Range (ATR)
- RGP 0.26
- BIOA 0.33
- MACD
- RGP -0.02
- BIOA 0.14
- Stochastic Oscillator
- RGP 21.57
- BIOA 83.10
About RGP Resources Connection Inc.
Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.